• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比马前列素的临床药理学

Clinical pharmacology of bimatoprost.

作者信息

Cantor Louis B

机构信息

Indiana University School of Medicine, USA.

出版信息

Expert Opin Drug Metab Toxicol. 2005 Jun;1(1):151-7. doi: 10.1517/17425255.1.1.151.

DOI:10.1517/17425255.1.1.151
PMID:16922657
Abstract

Bimatoprost (Lumigan), Allergan) is a highly efficacious ocular hypotensive agent that provides good diurnal control of intraocular pressure in glaucoma and ocular hypertensive patients. Bimatoprost is a synthetic molecule that is structurally and pharmacologically similar to prostamide F(2), and appears to mimic the activity of the prostamides. Consistent with prostamide-mimetic activity, bimatoprost has potent inherent pharmacological activity in prostamide-sensitive preparations and essentially remains intact in the living primate eye. This is sufficient to explain its potent and efficacious ocular hypotensive activity, and suggests that bimatoprost is a pharmacologically unique compound.

摘要

比马前列素(卢美根,艾尔建公司生产)是一种高效的降眼压药物,可有效控制青光眼和高眼压症患者的日间眼压。比马前列素是一种合成分子,其结构和药理作用与前列腺素F(2)类似,似乎能模拟前列腺素的活性。与模拟前列腺素的活性一致,比马前列素在对前列腺素敏感的制剂中具有强大的固有药理活性,并且在灵长类动物的活体眼中基本保持完整。这足以解释其强大而有效的降眼压活性,并表明比马前列素是一种药理特性独特的化合物。

相似文献

1
Clinical pharmacology of bimatoprost.比马前列素的临床药理学
Expert Opin Drug Metab Toxicol. 2005 Jun;1(1):151-7. doi: 10.1517/17425255.1.1.151.
2
The pharmacology of bimatoprost (Lumigan).比马前列素(卢美根)的药理学
Surv Ophthalmol. 2001 May;45 Suppl 4:S337-45. doi: 10.1016/s0039-6257(01)00224-7.
3
Bimatoprost: a novel antiglaucoma agent.比马前列素:一种新型抗青光眼药物。
Cardiovasc Drug Rev. 2004 Summer;22(2):103-20. doi: 10.1111/j.1527-3466.2004.tb00134.x.
4
Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.局部用比马前列素:其在开角型青光眼和高眼压症中应用的综述
Drugs Aging. 2002;19(3):231-48. doi: 10.2165/00002512-200219030-00008.
5
Bimatoprost, prostamide activity, and conventional drainage.比马前列素、前列腺酰胺活性与传统引流
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4107-15. doi: 10.1167/iovs.07-0080.
6
Mechanism of action of bimatoprost (Lumigan).比马前列素(卢美根)的作用机制。
Surv Ophthalmol. 2001 May;45 Suppl 4:S347-51. doi: 10.1016/s0039-6257(01)00213-2.
7
Ocular hypotensive efficacy of bimatoprost when used as a replacement for latanoprost in the treatment of glaucoma and ocular hypertension.
J Ocul Pharmacol Ther. 2003 Jun;19(3):193-203. doi: 10.1089/108076803321908329.
8
Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.比马前列素和曲伏前列素:两种新型青光眼药物的近期研究综述
Surv Ophthalmol. 2002 Aug;47 Suppl 1:S105-15. doi: 10.1016/s0039-6257(02)00327-2.
9
Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.一项为期六个月的随机临床试验,比较比马前列素和拉坦前列素对高眼压症或青光眼患者降低眼压的疗效。
Am J Ophthalmol. 2003 Aug;136(2):392; author reply 392-3. doi: 10.1016/s0002-9394(03)00247-2.
10
Latanoprost versus bimatoprost.拉坦前列素与比马前列素的对比
Ophthalmology. 2003 Sep;110(9):1861-2; author reply 1862. doi: 10.1016/S0161-6420(03)00849-2.

引用本文的文献

1
Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation.比马前列素前房内植入物(Durysta®):通过缓释创新开启青光眼治疗新时代。
Drug Des Devel Ther. 2025 Jan 31;19:703-714. doi: 10.2147/DDDT.S506520. eCollection 2025.
2
Analysis of Bimatoprost-Induced changes on Rabbits eyelash Follicle: Clinical and Electron microscopic study.比马前列素对兔睫毛毛囊影响的分析:临床与电子显微镜研究
Clin Ophthalmol. 2019 Dec 5;13:2421-2426. doi: 10.2147/OPTH.S229335. eCollection 2019.
3
Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.
治疗青光眼、年龄相关性黄斑变性和葡萄膜炎的新兴疗法的近期专利
Recent Pat Biomed Eng. 2012 Apr 1;5(1):83-101. doi: 10.2174/1874764711205010083.
4
Hirsutism following the use of bimatoprost eyedrops for glaucoma.使用比马前列素滴眼液治疗青光眼后出现多毛症。
J Pharmacol Pharmacother. 2014 Jul;5(3):208-10. doi: 10.4103/0976-500X.136110.
5
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.前列腺素类似物在治疗眼压升高和高眼压症中的临床应用及差异效应。
Clin Ophthalmol. 2010 Jul 30;4:741-64. doi: 10.2147/opth.s10441.
6
Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.前列腺素的作用以及比马前列素在治疗眼压升高和高眼压症中的特定治疗地位:深入探讨比马前列素和前列腺酰胺的激动剂特性。
Clin Ophthalmol. 2009;3:663-70. doi: 10.2147/opth.s6337. Epub 2009 Dec 29.
7
Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea.降眼压药物(PGF2α 类似物-比马前列素、拉坦前列素和曲伏前列素)与兔角膜上的 MDR 外排泵的相互作用。
J Ocul Pharmacol Ther. 2009 Dec;25(6):487-98. doi: 10.1089/jop.2009.0049.